PM
Potrero Medical, Inc.
SEC filingBiotechnology · Hayward, CA
Amount raised$6.5Msold at filing
Total offering$6.5M
Investors in the raise56count reported to the SEC
FiledMay 29, 2026first sale May 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mark GoldwasserDirector
Ram ReddyDirector
Rich KeenanExecutive Officer
Maurice FerreDirector
Todd DunnExecutive Officer
Mike StanskyDirector
David MatlinDirector
Khalid GhafariExecutive Officer
Christopher DeweyDirector
Clay HeightenDirector
Executive officers, directors and promoters as listed on the Form D.